Cargando…
Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients
Metformin, the first-line drug in type 2 diabetes mellitus, elicits cardiovascular protection also in obese patients via pleiotropic effects, among which the anti-oxidant is one of the most investigated. The aim of the present study was to assess whether metformin can acutely mitigate oxidative stre...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785172/ https://www.ncbi.nlm.nih.gov/pubmed/36556423 http://dx.doi.org/10.3390/life12122058 |
_version_ | 1784857984274268160 |
---|---|
author | Lascu, Ana Ionică, Loredana-Nicoleta Merce, Adrian-Petru Dănilă, Maria-Daniela Petrescu, Lucian Sturza, Adrian Muntean, Danina-Mirela Streian, Caius Glad |
author_facet | Lascu, Ana Ionică, Loredana-Nicoleta Merce, Adrian-Petru Dănilă, Maria-Daniela Petrescu, Lucian Sturza, Adrian Muntean, Danina-Mirela Streian, Caius Glad |
author_sort | Lascu, Ana |
collection | PubMed |
description | Metformin, the first-line drug in type 2 diabetes mellitus, elicits cardiovascular protection also in obese patients via pleiotropic effects, among which the anti-oxidant is one of the most investigated. The aim of the present study was to assess whether metformin can acutely mitigate oxidative stress in atrial tissue harvested from overweight non-diabetic patients. Right atrial appendage samples were harvested during open-heart surgery and used for the evaluation of reactive oxygen species (ROS) production by means of confocal microscopy (superoxide anion) and spectrophotometry (hydrogen peroxide). Experiments were performed after acute incubation with metformin (10 µM) in the presence vs. absence of angiotensin II (AII, 100 nM), lipopolysaccharide (LPS, 1 μg/mL), and high glucose (Gluc, 400 mg/dL). Stimulation with AII, LPS, and high Gluc increased ROS production. The magnitude of oxidative stress correlated with several echocardiographic parameters. Metformin applied in the lowest therapeutic concentration (10 µM) was able to decrease ROS generation in stimulated but also non-stimulated atrial samples. In conclusion, in a pilot group of overweight non-diabetic cardiac patients, acute incubation with metformin at a clinically relevant dose alleviated oxidative stress both in basal conditions and conditions that mimicked the activation of the renin–angiotensin–aldosterone system, acute inflammation, and uncontrolled hyperglycemia. |
format | Online Article Text |
id | pubmed-9785172 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97851722022-12-24 Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients Lascu, Ana Ionică, Loredana-Nicoleta Merce, Adrian-Petru Dănilă, Maria-Daniela Petrescu, Lucian Sturza, Adrian Muntean, Danina-Mirela Streian, Caius Glad Life (Basel) Article Metformin, the first-line drug in type 2 diabetes mellitus, elicits cardiovascular protection also in obese patients via pleiotropic effects, among which the anti-oxidant is one of the most investigated. The aim of the present study was to assess whether metformin can acutely mitigate oxidative stress in atrial tissue harvested from overweight non-diabetic patients. Right atrial appendage samples were harvested during open-heart surgery and used for the evaluation of reactive oxygen species (ROS) production by means of confocal microscopy (superoxide anion) and spectrophotometry (hydrogen peroxide). Experiments were performed after acute incubation with metformin (10 µM) in the presence vs. absence of angiotensin II (AII, 100 nM), lipopolysaccharide (LPS, 1 μg/mL), and high glucose (Gluc, 400 mg/dL). Stimulation with AII, LPS, and high Gluc increased ROS production. The magnitude of oxidative stress correlated with several echocardiographic parameters. Metformin applied in the lowest therapeutic concentration (10 µM) was able to decrease ROS generation in stimulated but also non-stimulated atrial samples. In conclusion, in a pilot group of overweight non-diabetic cardiac patients, acute incubation with metformin at a clinically relevant dose alleviated oxidative stress both in basal conditions and conditions that mimicked the activation of the renin–angiotensin–aldosterone system, acute inflammation, and uncontrolled hyperglycemia. MDPI 2022-12-08 /pmc/articles/PMC9785172/ /pubmed/36556423 http://dx.doi.org/10.3390/life12122058 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lascu, Ana Ionică, Loredana-Nicoleta Merce, Adrian-Petru Dănilă, Maria-Daniela Petrescu, Lucian Sturza, Adrian Muntean, Danina-Mirela Streian, Caius Glad Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients |
title | Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients |
title_full | Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients |
title_fullStr | Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients |
title_full_unstemmed | Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients |
title_short | Metformin Acutely Mitigates Oxidative Stress in Human Atrial Tissue: A Pilot Study in Overweight Non-Diabetic Cardiac Patients |
title_sort | metformin acutely mitigates oxidative stress in human atrial tissue: a pilot study in overweight non-diabetic cardiac patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785172/ https://www.ncbi.nlm.nih.gov/pubmed/36556423 http://dx.doi.org/10.3390/life12122058 |
work_keys_str_mv | AT lascuana metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients AT ionicaloredananicoleta metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients AT merceadrianpetru metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients AT danilamariadaniela metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients AT petresculucian metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients AT sturzaadrian metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients AT munteandaninamirela metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients AT streiancaiusglad metforminacutelymitigatesoxidativestressinhumanatrialtissueapilotstudyinoverweightnondiabeticcardiacpatients |